WHO ICTRP trial
CAPRISA 018 TAF Implant Trial
PACTR201809520959443 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR201809520959443 |
|---|---|
| Public title | CAPRISA 018 TAF Implant Trial |
| Scientific title | A phase I/II trial to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide sub-dermal implant for HIV prevention in women |
| Primary sponsor | Centre for the AIDS Programme of Research in Sauth Africa |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-1 |
| Countries | South Africa;South Africa |
| Conditions | HIV/AIDS;HIV/AIDS |
| Interventions | tenofovir alafenamide;tenofovir disoproxil fumarate and emtricitabine;Tenofovir alafenamide implant |
| Registration date | Oct 9, 2018 |
| Target size | 550 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: